Výsledky vyhledávání - "Karagenç N."

Akademický článek

The frequency of EGFR And KRAS mutations in the Turkish population with non-small cell lung cancer and their response to erlotinib therapy

Autor: Demiray A, Yaren A, Karagenç N, Bir F, Demiray AG, Karagür ER, Tokgün O, Elmas L, Akça H

Publikováno v: Balkan Journal of Medical Genetics, Vol 21, Iss 2, Pp 21-26 (2018)

In this study, profiles of epidermal growth factor receptor (EGFR) and Kirsten ras sarcoma (KRAS) mutations and response to erlotinib therapy have been investigated in patients with non-small cell lung cancer (NSCLC). DNA from 300 patients with NSCLC

Externí odkaz: https://doaj.org/article/0d5a64cd0f4d4cec81b435f8025d41f8

Zobrazit plný text záznamu

Plný text ve formátu HTML

The impact of hereditary thrombophilias in recurrent pregnancy loss

Autor: Karagür, E.R., Alay, M.T., Demiray, A., Karagenç, N., Tokgün, O., Durak, T., Akca, H.

Publikováno v: Genetika. 54:1399-1410

Introduction: Recurrent pregnancy loss (RPL) is defined as two or more consecutive pregnancy loss which occurs before the 20th weeks of pregnancies for the last menstrual period. Hereditary cause of thrombophilic gene mutations and polymorphism may p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88f5702ea1f915d53e0a6ee58aa69278
https://doi.org/10.2298/gensr2203399k

Zobrazit plný text záznamu

IS THERE AN ADVANTAGE OF MONITORING VIA EXOSOME-BASED DETECTION OF EGFR MUTATIONS DURING TREATMENT IN NON-SMALL CELL LUNG CANCER PATIENTS? [DA LI POSTOJI PREDNOST MONITORINGA PREKO DETEKCIJE EGFR MUTACIJA TOKOM LEČENJA PACIJENATA SA RAKOM PLUĆA]

Autor: Karagur, E.R., Demiray, A., Karagenç, N., Elver, E.R., Tokgün, O., Yaren, A., Doğu, G.G.

We know that detection of EGFR mutations is very important for individual therapy. Nowadays FFPE samples are commonly using to detect the EGFR mutation status. But it has a few handicaps such as, tumor heterogeneity and non-repeatable, it is need to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10652::e5ca6f5c72056001390c7099b821799b
https://hdl.handle.net/11499/51302

Zobrazit plný text záznamu

Two Novel CEBPA Mutations in a Turkish Patient with Acute Myeloid Leukemia

Autor: T Durak, Pervin Elvan Tokgun, Onur Tokgun, N Güler, S Atli Tekin, Hakan Akca, M T Alay, B Celik, Karagenç N, Aydın Demiray

Publikováno v: Balkan Journal of Medical Genetics : BJMG
Balkan Journal of Medical Genetics, Vol 23, Iss 2, Pp 99-102 (2021)

Acute myeloid leukemia (AML) was first categorized in 1976 by French, American and British researchers, and divided into eight subgroups (M0 to M7), depending on the cytochemical or histological changes in the leukemic cells. The gene mutations of FL

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e9d5c789f282befc8cf99cd3329011f
http://europepmc.org/articles/PMC8009566

Zobrazit plný text záznamu

The frequency of EGFR And KRAS mutations in the Turkish population with non-small cell lung cancer and their response to erlotinib therapy

Autor: Hakan Akca, Ferda Bir, Karagenç N, Aydın Demiray, Levent Elmas, Demiray Ag, Karagür Er, Arzu Yaren, Onur Tokgun

Publikováno v: Balkan Journal of Medical Genetics, Vol 21, Iss 2, Pp 21-26 (2018)
Balkan Journal of Medical Genetics : BJMG

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398f472afeba29b7b1624bc9a80bf89b
https://doaj.org/article/0d5a64cd0f4d4cec81b435f8025d41f8

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání